Executive Summary
This India Trading Suspensions & Delistings stream for 2026-10-26 contains three filings, but only one falls squarely within the stream's Regulatory Action focus with usable substance.
The Samvardhana Motherson scheme (NCLT-approved demerger and amalgamation, appointed date April 1, 2024) is a corporate restructuring event rather than a suspension or delisting, so it sits at the edge of scope; it is retained given the regulatory approval element. The two SEBI recovery filings (Austral Coke-related completion order and Add Life Pharma General Remittance Order) are genuine regulatory enforcement actions, both negatively toned, but neither discloses monetary amounts, deadlines, or operational impact. The enriched data provided contains no period-over-period financial comparisons, forward guidance, insider transactions, capital allocation figures, or valuation metrics for any filing, so trend synthesis and cross-company metric comparison are not possible. The dominant market implication is limited: enforcement pressure on promoter-linked and pharma entities is noted, but without quantified exposure the signal is informational rather than actionable.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Insolvency
Tracking the trend? Catch up on the prior India BSE NSE Trading Suspension Orders digest from October 17, 2026.
Investment Signals (3)
- Samvardhana Motherson International ↓ (NEUTRAL)▲
NCLT approval of demerger and amalgamation with an April 1, 2024 appointed date signals a completed structural step, with no new share issuance by the company
- Add Life Pharma Ltd (BEARISH)▲
SEBI General Remittance Order under Recovery Certificate No. 8511 of 2025 indicates an outstanding recovery demand is being enforced, with no quantum disclosed
- Austral Coke and Projects / Narendrabhai Amin (NEUTRAL)▲
SEBI completion order closing Recovery Certificate No. 8484 of 2024 suggests the recovery matter is resolved, a mildly constructive closure event for the related entity
Risk Flags (4)
- Add Life Pharma Ltd / SEBI Enforcement [HIGH RISK]▼
Active SEBI recovery proceeding with undisclosed recoverable amount, underlying violation, and compliance deadline; the filing's silence on quantum is itself a diligence gap
- Austral Coke and Projects / Promoter-Linked Enforcement [MEDIUM RISK]▼
Enforcement history involving an individual (PAN AMGPA3864Q) tied to the company, although the 2026 order is a closure step
- Samvardhana Motherson / Scheme Execution↓ [MEDIUM RISK]▼
Scheme requires cancellation of share capital of two subsidiaries and a demerger with an appointed date that predates filing by roughly two and a half years, raising questions about approval timeline and effective-date conditions
- Stream Data Quality / Enrichment Gap [MEDIUM RISK]▼
No period comparisons, insider activity, guidance, capital allocation, or financial ratios were supplied for any filing, so quantitative risk assessment cannot be performed
Opportunities (2)
- Samvardhana Motherson / Demerger Effective Date↓ (OPPORTUNITY)◆
NCLT sanction opens the path to effective-date completion; investors should track the demerged-undertaking separation for value-unlocking clarity in the auto-components group
- Austral Coke and Projects / Overhang Removal (OPPORTUNITY)◆
Closure of Recovery Certificate No. 8484 of 2024 removes an enforcement overhang on the related entity, a potential re-rating catalyst if confirmed by the company's own disclosures
Sector Themes (2)
- Regulatory Enforcement Concentration◆
Two of three filings are SEBI recovery actions, one closing and one initiating enforcement, indicating ongoing clean-up of legacy fraud-investigation matters across smaller listed names
- Restructuring via NCLT Schemes◆
The Samvardhana Motherson scheme reflects continued use of Sections 230-232 composite schemes to reorganise Indian group structures, with demergers and subsidiary amalgamations as the primary tools
Watch List (5)
-
NCLT-approved scheme awaiting effective date and filings to Registrar of Companies; monitor for effective-date announcement and share-capital cancellation details
- Add Life Pharma Ltd👁
SEBI recovery demand outstanding; watch for disclosure of recoverable amount, any compliance deadline, and whether enforcement escalates to trading restrictions
- Austral Coke and Projects👁
Post-closure of Recovery Certificate No. 8484 of 2024; watch for company-level confirmation and any residual exchange surveillance action
- SEBI Recovery Proceedings Register👁
Monitor further recovery certificates in the same enforcement category for potential suspension or delisting precursors
- Stream Coverage Gap👁
Request enriched financial and insider data for the three filings to enable quantitative assessment in the next digest cycle
Filing Analyses
(3)
26-10-2026
Samvardhana Motherson International Limited disclosed under Regulation 30 of SEBI LODR that the Hon'ble NCLT, Mumbai Bench-II, approved via order dated October 26, 2026, a composite scheme of arrangement under Sections 230-232 of the Companies Act, 2013 involving the company, three wholly owned subsidiaries, and their shareholders. The scheme provides for a demerger of the Demerged Undertaking of Samvardhana Motherson Innovative Solutions Limited into the company and amalgamations of two subsidiaries, with an appointed date of April 1, 2024. No new shares will be issued by the company, and the share capital of the two amalgamating subsidiaries will be cancelled.
- · Appointed Date of the scheme is April 1, 2024
- · The Demerged Company is a 100% subsidiary of the Resulting Company, so no shares will be issued by the company under the demerger
- · The entire share capital of Samvardhana Motherson Auto System Private Limited and Motherson Machinery and Automations Limited will be cancelled on the Effective Date
- · The Board of each petitioner company approved the scheme on February 7, 2025
- · The Regional Director, Ministry of Corporate Affairs (Western Region-I) was represented at the hearing
- · The Tribunal's order is subject to the petitioners' undertaking to comply with statutory requirements under the Companies Act, 2013
26-10-2026
SEBI has issued a completion order for Recovery Certificate No. 8484 of 2024 against Narendrabhai Amin (PAN AMGPA3864Q) in connection with M/s Austral Coke and Projects Limited. The order confirms closure of the recovery proceedings initiated under the 2024 certificate, and no monetary amounts, percentages or period comparisons are disclosed in the filing excerpt.
- · Recovery Certificate No. 8484 of 2024 was issued by SEBI and is now subject to a completion order dated October 26, 2026
- · The proceeding is categorised under SEBI's Enforcement - Recovery Proceedings section
26-10-2026
SEBI issued a General Remittance Order dated 26 October 2026 under Recovery Certificate No. 8511 of 2025 against Add Life Pharma Ltd, directing compliance with an outstanding recovery demand. The filing is a regulator-initiated enforcement step to recover amounts owed, with no monetary amount, penalty quantum, or operational impact disclosed in the document provided.
- · Order reference: Recovery Certificate No. 8511 of 2025, issued by SEBI under its Recovery Proceedings enforcement category
- · The filing does not disclose the recoverable amount, the underlying violation, or the compliance deadline
Get daily alerts with 3 investment signals, 4 risk alerts, 2 opportunities and full AI analysis of all 3 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India BSE NSE Trading Suspension Orders
October 16, 2026
India BSE NSE Trading Suspension Orders — October 16, 2026
October 15, 2026
India BSE NSE Trading Suspension Orders — October 15, 2026
October 14, 2026
India BSE NSE Trading Suspension Orders — October 14, 2026
October 13, 2026
India BSE NSE Trading Suspension Orders — October 13, 2026
🇮🇳 More from India
View all →October 19, 2026
India Quarterly Results BSE NSE Announcements — October 19, 2026
India Quarterly Results BSE NSE Announcements
October 19, 2026
India Pre-Market Regulatory Roundup — October 19, 2026
India Pre-Market Regulatory Roundup
October 19, 2026
India Upcoming Corporate Actions BSE NSE — October 19, 2026
India Upcoming Corporate Actions BSE NSE
October 19, 2026
BSE Sensex 30 Stocks Regulatory Filings — October 19, 2026
BSE Sensex 30 Stocks Regulatory Filings